October 10, 2025

FDA Broadens Label for Schizophrenia Drug

The FDA has approved a new long-acting injectable treatment option for adults with bipolar I disorder.

Conexiant

October 10, 2025

Seaport Criteria Bring Clarity to Myocarditis Grading

New guidelines combine H&E and CD3 staining to improve diagnostic accuracy and reproducibility worldwide

The Pathologist

October 10, 2025

Adolescent and Adult VTE After Arthroscopy Compared in Study

Lower venous thromboembolism risk is shown in adolescents than adults after knee arthroscopy, but comorbidities like diabetes and obesity raise risk.

Conexiant

October 09, 2025

Is Postoperative AF Changing Anticoagulation Decisions?

Cohort of 198 coronary artery bypass grafting patients monitored for 1 year with insertable cardiac devices found high incidence of new-onset atrial fibrillation but minimal late burden.

Conexiant

October 08, 2025

Contemporary Management of Chronic Myeloid Leukemia, According to Hagop M. Kantarjian, MD, FASCO

Chronic myeloid leukemia (CML) is one of the success stories among the hematologic malignancies. Now, with decades of data informing its management, it is time to change some of the practices to which...

The ASCO Post

October 06, 2025

Evidence-Based Medicine Requires Urgent Reform, Physician Says

Systemic biases and industry influence have undermined the movement's foundational principles, potentially compromising patient care across multiple specialties.

Conexiant

October 06, 2025

Large Language Models and Foundation Models in Ophthalmology

How can we democratize ophthalmic care with AI?

The Ophthalmologist

October 06, 2025

Hypertension Drove Atrial Fibrillation Across Study Periods

Incidence rose 44% over three decades, with hypertension as primary driver in all periods

Conexiant

October 02, 2025

FDA Removes Vandetanib REMS Program

On September 25, the U.S. Food and Drug Administration (FDA) removed the Risk Evaluation and Mitigation Strategies (REMS) program for vandetanib, according to an announcement from the agency. 

The ASCO Post